Benzinga | Aug 6, 2020 05:11PM EDT

Chembio Diagnostics Q2 EPS $(0.42) Misses $(0.39) Estimate, Sales $5.11M Miss $6.88M Estimate

Chembio Diagnostics (NASDAQ:CEMI) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.39) by 7.69 percent. This is a 121.05 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $5.11 million which missed the analyst consensus estimate of $6.88 million by 25.71 percent. This is a 46.71 percent decrease over sales of $9.59 million the same period last year.